Log In
BCIQ
Print this Print this
 

vadastuximab talirine (33A, SGN-CD33A)

  Manage Alerts
Collapse Summary General Information
Company Seattle Genetics Inc.
DescriptionHumanized mAb against CD33 conjugated to 2 pyrrolobenzodiazepine (PBD) dimer moieties
Molecular Target CD33
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today